These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8178733)

  • 1. Comparison of continuous infusions and bolus injections of 5-fluorouracil with or without leucovorin: implications for inhibition of thymidylate synthase.
    Peters GJ; Codacci-Pisanelli G; van der Wilt CL; van Laar JA; Smid K; Noordhuis P; Pinedo HM
    Adv Exp Med Biol; 1993; 339():9-20; discussion 21. PubMed ID: 8178733
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of leucovorin on 5-fluorouracil induced inhibition of thymidylate synthase in patients with colon cancer.
    Peters GJ; van Groeningen CJ; van der Wilt CL; Smid K; Meijer S; Pinedo HM
    Adv Exp Med Biol; 1991; 309A():131-4. PubMed ID: 1789191
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil.
    Peters GJ; van der Wilt CL; van Groeningen CJ; Smid K; Meijer S; Pinedo HM
    J Clin Oncol; 1994 Oct; 12(10):2035-42. PubMed ID: 7931471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice.
    Codacci-Pisanelli G; van der Wilt CL; Pinedo HM; Franchi F; Noordhuis P; Braakhuis BJ; van Laar JA; Peters GJ
    Eur J Cancer; 1995; 31A(9):1517-25. PubMed ID: 7577082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic strategies for patients with gastrointestinal malignancies using biochemical modulation of fluorouracil.
    Allegra CJ
    JAMA; 1995 Jan; 273(3):236-9. PubMed ID: 7807664
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.
    Allegra CJ; Egan GF; Drake JC; Steinberg SM; Swain SM
    Adv Exp Med Biol; 1988; 244():107-12. PubMed ID: 3266821
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer].
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Fukunaga T; Aihara N
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2077-81. PubMed ID: 14712768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of a new inhibitor of thymidylate synthase: 'Tomudex' (raltitrexed).
    Cunningham D
    Tumori; 1997; 83(1 Suppl):S70-1. PubMed ID: 9154074
    [No Abstract]   [Full Text] [Related]  

  • 10. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase.
    Morgan RG
    Cancer; 1989 Mar; 63(6 Suppl):1008-12. PubMed ID: 2521810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
    Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
    Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interval between methotrexate and leucovorin determines the efficacy of 5-fluorouracil modulation in vitro and in vivo.
    van der Wilt CL; de Jong M; Braakhuis BJ; Pinedo HM; Peters GJ
    Adv Exp Med Biol; 1993; 338():609-12. PubMed ID: 8304191
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
    Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
    J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination.
    Cascinu S; Catalano V; Aschele C; Barni S; Debernardis D; Gallo L; Bandelloni R; Staccioli MP; Baldelli AM; Brenna A; Valenti A; Muretto P; Catalano G
    Ann Oncol; 2000 Aug; 11(8):1053-6. PubMed ID: 11038045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer.
    Hageboutros A; Rogatko A; Newman EM; McAleer C; Brennan J; LaCreta FP; Hudes GR; Ozols RF; O'Dwyer PJ
    Cancer Chemother Pharmacol; 1995; 35(3):205-12. PubMed ID: 7805178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.
    Cascinu S; Aschele C; Barni S; Debernardis D; Baldo C; Tunesi G; Catalano V; Staccioli MP; Brenna A; Muretto P; Catalano G
    Clin Cancer Res; 1999 Aug; 5(8):1996-9. PubMed ID: 10473077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.
    Alexander HR; Grem JL; Hamilton JM; Pass HI; Hong M; Fraker DL; Steinberg SM; McAtee N; Allegra BC; Johnston PG
    Cancer J Sci Am; 1995; 1(1):49-54. PubMed ID: 9166454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Puzzles in the clinical pharmacokinetics of fluorouracil.
    Desoize B; Bouche O; Berthiot G; Coninx P
    Anticancer Res; 1998; 18(6B):4607-10. PubMed ID: 9891526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating fluorouracil with different drugs: the Padua experience.
    Fiorentino MV; Fornasiero A; Daniele O
    J Chemother; 1990 Feb; 2 Suppl 1():51-4. PubMed ID: 2366071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potentiation of thymidylate synthetase (TS) inhibition by combined administration of HCFU and dipyridamole: preliminary report. Kinki Cooperative Study Group of Chemotherapy for Colorectal Carcinoma].
    Kikkawa N; Kato T; Iwanaga T; Utsunomiya J; Hioki K; Mori T; Yasutomi M; Fukuda I; Kameyama M
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1083-6. PubMed ID: 1626945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.